company background image
NAN logo

Nanosonics CHIA:NAN Stock Report

Last Price

AU$3.24

Market Cap

AU$976.8m

7D

-5.0%

1Y

-23.2%

Updated

25 Nov, 2024

Data

Company Financials +

Nanosonics Limited

CHIA:NAN Stock Report

Market Cap: AU$976.8m

NAN Stock Overview

Operates as an infection prevention company globally. More details

NAN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 35.7% below our estimate of its fair value

Earnings are forecast to grow 23.96% per year

Risk Analysis

Profit margins (7.6%) are lower than last year (12%)


Nanosonics Limited Competitors

Ansell

ASX:ANN

AU$4.7b

SDI

ASX:SDI

AU$125.4m

Paragon Care

ASX:PGC

AU$827.7m

Australian Clinical Labs

ASX:ACL

AU$697.5m

Price History & Performance

Summary of all time highs, changes and price drops for Nanosonics
Historical stock prices
Current Share PriceAU$3.24
52 Week HighAU$4.75
52 Week LowAU$2.59
Beta1.56
11 Month Change-2.41%
3 Month Change-2.41%
1 Year Change-23.22%
33 Year Change-40.44%
5 Year Change-52.28%
Change since IPO307.55%

Recent News & Updates

Recent updates

Shareholder Returns

NANAU Medical EquipmentAU Market
7D-5.0%0.5%0.9%
1Y-23.2%14.8%18.4%

Return vs Industry: NAN underperformed the Australian Medical Equipment industry which returned 14.8% over the past year.

Return vs Market: NAN underperformed the Australian Market which returned 18.4% over the past year.

Price Volatility

Is NAN's price volatile compared to industry and market?
NAN volatility
NAN Average Weekly Movement8.0%
Medical Equipment Industry Average Movement9.4%
Market Average Movement8.5%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market3.2%

Stable Share Price: NAN has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: NAN's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000466Michael Kavanaghwww.nanosonics.com.au

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.

Nanosonics Limited Fundamentals Summary

How do Nanosonics's earnings and revenue compare to its market cap?
NAN fundamental statistics
Market capAU$976.84m
Earnings (TTM)AU$12.97m
Revenue (TTM)AU$170.01m

75.3x

P/E Ratio

5.7x

P/S Ratio

Is NAN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NAN income statement (TTM)
RevenueAU$170.01m
Cost of RevenueAU$37.58m
Gross ProfitAU$132.44m
Other ExpensesAU$119.47m
EarningsAU$12.97m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.043
Gross Margin77.90%
Net Profit Margin7.63%
Debt/Equity Ratio0%

How did NAN perform over the long term?

See historical performance and comparison